Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Redhill Biopharma ADR News

    0,4187 $ -0,29% -0,0012 $
    In : 0,3902 € | 22:00:04 Uhr Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3D9SL
    ISIN: US7574682024
    US-Symbol: RDHL
    Typ: Aktie

    Redhill Biopharma ADR News

    24.04.24 - PR Newswire
    RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
    RedHill Announces First Patient Enrolled in U.S. Government-​Supported COVID-19 Study PR Newswire
    08.04.24 - PR Newswire
    RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
    RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights PR Newswire
    02.04.24 - PR Newswire
    RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
    RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price PR Newswire
    11.03.24 - PR Newswire
    RedHill Announces New USPTO Patent Covering Talicia® Through 2034
    RedHill Announces New USPTO Patent Covering Talicia® Through 2034 PR Newswire
    05.03.24 - PR Newswire
    RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs
    RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs PR Newswire
    20.02.24 - PR Newswire
    RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication
    RedHill's Opaganib Protects Against Radiation-​Induced Lung Inflammation and Fibrosis - New Publication PR Newswire
    26.01.24 - PR Newswire
    RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering
    RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering PR Newswire
    25.01.24 - PR Newswire
    RedHill Biopharma Announces $8 Million Registered Direct Offering
    RedHill Biopharma Announces $8 Million Registered Direct Offering PR Newswire
    25.01.24 - PR Newswire
    RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042
    RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042 PR Newswire
    24.01.24 - PR Newswire
    Thinking about buying stock in Kura Oncology, UiPath, C3.ai, Crowdstrike, or RedHill Biopharma?
    Thinking about buying stock in Kura Oncology, UiPath, C3.ai, Crowdstrike, or RedHill Biopharma? PR Newswire
    20.12.23 - PR Newswire
    RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola
    RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola PR Newswire
    12.12.23 - PR Newswire
    RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
    RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire
    04.12.23 - PR Newswire
    Thinking about buying stock in Broadcom, Bitfarms, RedHill Biopharma, Garden Stage, or Virgin Galactic Holdings?
    Thinking about buying stock in Broadcom, Bitfarms, RedHill Biopharma, Garden Stage, or Virgin Galactic Holdings? PR Newswire
    04.12.23 - PR Newswire
    RedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 Study
    RedHill Announces New, Non-​Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 Study PR Newswire
    29.11.23 - PR Newswire
    Thinking about buying stock in RedHill Biopharma, Mynaric, Energy Transfer LP, Seelos Therapeutics, or Petco Health and Wellness?
    Thinking about buying stock in RedHill Biopharma, Mynaric, Energy Transfer LP, Seelos Therapeutics, or Petco Health and Wellness? PR Newswire
    27.11.23 - PR Newswire
    RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034
    RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034 PR Newswire
    14.11.23 - PR Newswire
    RedHill Biopharma Announces the Transfer of its Listing to The Nasdaq Capital Market
    RedHill Biopharma Announces the Transfer of its Listing to The Nasdaq Capital Market PR Newswire
    04.10.23 - PR Newswire
    Thinking about buying stock in ALX Oncology Holdings, RedHill Biopharma, Freeline Therapeutics Holdings, Terawulf, or I-Mab?
    Thinking about buying stock in ALX Oncology Holdings, RedHill Biopharma, Freeline Therapeutics Holdings, Terawulf, or I-Mab? PR Newswire
    03.10.23 - PR Newswire
    RedHill and U.S. Army Announce Opaganib's Ebola Virus Disease Survival Benefit in U.S. Army-Funded In-Vivo Study
    RedHill and U.S. Army Announce Opaganib's Ebola Virus Disease Survival Benefit in U.S. Army-​Funded In-Vivo Study PR Newswire
    22.09.23 - PR Newswire
    RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
    RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency PR Newswire

    Newssuche

    Videos

    09:30 Uhr +21,95%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »